By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Waters today reported revenues grew 14 percent year over year in the second quarter, but missed analysts' estimates on soft sales to government and academic customers.

For the three months ended July 2, the company posted $447.6 million in revenues, up from $391.1 million a year ago, but short of Wall Street's consensus estimate of $451.1 million.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Researchers hope to tease out the signature effects that different carcinogens leave on the genome to determine their contributions to disease, Mosaic reports.

The Wall Street Journal looks into the cost of new gene therapies.

An Imperial College London-led team reports that it was able to use a gene drive to control a population of lab mosquitos.

In PNAS this week: genomic effects of silver fox domestication, limited effect of mitochondrial mutations on aging in fruit flies, and more.